ArticleJournal of the American Heart Association2026
Hypertension Prevalence, Diagnosis, and Management for Post-9/11 US Veterans.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension prevalence, diagnosis, and treatment vary by age, sex, and race and ethnicity in the general US population and for veterans. Less is known about the youngest veterans (ie, discharged post-9/11), including growing subsets of women and some racial and ethnic subgroups.
methodsIn this cross-sectional study, national Veterans Health Administration data were used to identify post-9/11 veterans receiving Veterans Health Administration care in 2001 to 2023. Proportions with clinical hypertension (patients with hypertension diagnostic code[s], antihypertensive medication fills, or blood pressure measurements ≥140/90), undiagnosed hypertension, and untreated hypertension were calculated. Crude and adjusted prevalence ratios for hypertension measures were presented by sex and by race and ethnicity, adjusting for demographics and comorbidities.
resultsAmong 1 181 007 veterans (mean age, 33.5±9.4 years; 12.3% women), 44.9% had clinical hypertension, among them 49% undiagnosed and 26% untreated. Compared with men, women were associated with 5% lower risk of clinical hypertension (adjusted prevalence ratio, 0.95 [95% CI, 0.93-0.96]) and untreated hypertension (adjusted prevalence ratio, 0.61 [95% CI, 0.60-0.63]) but had higher risk of undiagnosed hypertension (adjusted prevalence ratio, 1.17 [95% CI, 1.16-1.18]). Compared with White veterans, Black veterans were associated with 9% higher risk of hypertension but 26% lower risk of undiagnosed and 19% lower risk of untreated hypertension.
conclusionsNearly half of post-9/11 veterans met hypertension criteria, and among them 49% were undiagnosed and 26% were untreated. Tailored screening and self-measured blood pressure monitoring to reduce prevalence and improve management might curb potential differences among these veterans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.